These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6756907)

  • 21. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 22. Joint trimethoprim and sulphamethoxazole resistance in bacteria infected with R factors.
    Pinney RJ; Smith JT
    J Med Microbiol; 1973 Feb; 6(1):13-9. PubMed ID: 4570475
    [No Abstract]   [Full Text] [Related]  

  • 23. Trimethoprim resistance and single-agent use.
    Maskell R; Pead L
    Lancet; 1989 Sep; 2(8662):557-8. PubMed ID: 2570249
    [No Abstract]   [Full Text] [Related]  

  • 24. Spurious sulfamethoxazole-trimethoprim resistance of Salmonella typhi.
    Escamilla J; Kilpatrick ME; Ugarte HF
    J Clin Microbiol; 1986 Jan; 23(1):205-6. PubMed ID: 3486190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of Haemophilus influenzae to trimethoprim.
    May JR; Davies J
    Br Med J; 1972 Aug; 3(5823):376-7. PubMed ID: 4538444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of bacterial resistance to trimethoprim-sulphamethoxazole using the single disc diffusion method.
    Kayser FH; Wüst J
    Chemotherapy; 1973; 18(3):162-8. PubMed ID: 4567769
    [No Abstract]   [Full Text] [Related]  

  • 27. Co-trimoxazole sensitivity testing: comparison of separate and combined disk agar diffusion techniques.
    Amyes SG; Telfer Brunton WA
    J Clin Pathol; 1981 Feb; 34(2):199-202. PubMed ID: 7229100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of co-trimoxazole on faecal enterobacteria: no emergence of resistant strains.
    Moorhouse EC; Farrell W
    J Med Microbiol; 1973 May; 6(2):249-52. PubMed ID: 4575275
    [No Abstract]   [Full Text] [Related]  

  • 29. Sensitivity of Pseudomonas aeruginosa to sulphonamides and trimethoprim and the activity of the combination trimethoprim: sulphamethoxazole.
    Grey D; Hamilton-Miller JM
    J Med Microbiol; 1977 Aug; 10(3):273-9. PubMed ID: 408490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli.
    Greenwood D; O'Grady F
    J Clin Pathol; 1976 Feb; 29(2):162-6. PubMed ID: 777036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility testing to trimethoprim alone and combined with sulphonamides.
    Dornbusch K; Gezelius L
    Chemotherapy; 1980; 26(6):418-26. PubMed ID: 7408555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trimethoprim-sulphamethoxazole-resistant Shigella dysenteriae serotype 1 (Shiga's bacillus) in Gimira, south-west Ethiopia.
    Gebre-Yohannes A; Belachew C
    Ethiop Med J; 1983 Oct; 21(4):275-6. PubMed ID: 6354711
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
    Focht J; Klietmann W; Nösner K
    Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of a novel trimethoprim-sulfamethoxazole-containing medium (XT80) with kanamycin agar for isolation of antibiotic-resistant organisms from stool and rectal cultures of marrow transplant patients.
    Hamilton DJ; Ulness BK; Baugher LK; Counts GW
    J Clin Microbiol; 1987 Oct; 25(10):1886-90. PubMed ID: 3312287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.
    Wormser GP; Keusch GT; Heel RC
    Drugs; 1982 Dec; 24(6):459-518. PubMed ID: 6759092
    [No Abstract]   [Full Text] [Related]  

  • 36. Biochemical background of trimethoprim-sulphamethoxazole.
    Hitchings GH
    Med J Aust; 1973 Jun; 1(2):Suppl:5-9. PubMed ID: 4580589
    [No Abstract]   [Full Text] [Related]  

  • 37. The action of trimethoprim-sulphamethoxazole against urinary pathogens.
    Smith DD; Bell SM; Levey JM; Loy YT
    Med J Aust; 1972 Feb; 1(6):263-5. PubMed ID: 4552261
    [No Abstract]   [Full Text] [Related]  

  • 38. Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.
    Sattler FR; Remington JS
    Eur J Clin Microbiol; 1984 Jun; 3(3):174-6. PubMed ID: 6332015
    [No Abstract]   [Full Text] [Related]  

  • 39. Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.
    Amyes SG
    Antimicrob Agents Chemother; 1982 Feb; 21(2):288-93. PubMed ID: 7041815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
    Shrire L; Saunders J; Traynor R; Koornhof HJ
    Eur J Clin Microbiol; 1984 Aug; 3(4):328-32. PubMed ID: 6237900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.